[go: up one dir, main page]

MXPA03003466A - Derivados de piranosido. - Google Patents

Derivados de piranosido.

Info

Publication number
MXPA03003466A
MXPA03003466A MXPA03003466A MXPA03003466A MXPA03003466A MX PA03003466 A MXPA03003466 A MX PA03003466A MX PA03003466 A MXPA03003466 A MX PA03003466A MX PA03003466 A MXPA03003466 A MX PA03003466A MX PA03003466 A MXPA03003466 A MX PA03003466A
Authority
MX
Mexico
Prior art keywords
derivatives
pyranoside derivatives
pyranoside
medicaments
production
Prior art date
Application number
MXPA03003466A
Other languages
English (en)
Inventor
Hans Michael Jennewein
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA03003466A publication Critical patent/MXPA03003466A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invencion se refiere a nuevos derivados de piranosido de formula general I, a procedimientos para su preparacion asi como a su uso como medicamentos. (Ver formula).
MXPA03003466A 2000-10-24 2001-10-19 Derivados de piranosido. MXPA03003466A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10052658A DE10052658A1 (de) 2000-10-24 2000-10-24 Neue Pyranosidderivate
PCT/EP2001/012128 WO2002034761A1 (de) 2000-10-24 2001-10-19 Pyranosidderivate

Publications (1)

Publication Number Publication Date
MXPA03003466A true MXPA03003466A (es) 2004-09-10

Family

ID=7660865

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003466A MXPA03003466A (es) 2000-10-24 2001-10-19 Derivados de piranosido.

Country Status (7)

Country Link
EP (1) EP1332151A1 (es)
JP (1) JP2004513100A (es)
AU (1) AU2002215965A1 (es)
CA (1) CA2426564A1 (es)
DE (1) DE10052658A1 (es)
MX (1) MXPA03003466A (es)
WO (1) WO2002034761A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005023797D1 (de) * 2004-07-14 2010-11-04 Inflammation Res Ct Co Ltd Verfahren zur Hemmung von Tumormetastasierung
US12275687B2 (en) * 2017-05-12 2025-04-15 Riken Class A GPCR-binding compound modifier

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19637123A1 (de) * 1996-09-12 1998-03-19 Boehringer Ingelheim Kg Neue Pyranosidderivate

Also Published As

Publication number Publication date
EP1332151A1 (de) 2003-08-06
DE10052658A1 (de) 2002-05-02
WO2002034761A1 (de) 2002-05-02
AU2002215965A1 (en) 2002-05-06
CA2426564A1 (en) 2002-05-02
JP2004513100A (ja) 2004-04-30

Similar Documents

Publication Publication Date Title
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
WO2002008190A3 (de) Neue heteroaryl-derivate und deren verwendung als antitumormittel
MY133392A (en) Novel substituted pyrazole derivatives
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
WO2002008194A8 (de) Acridin-derivate und deren verwendung als arzneimittel
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
MXPA03008754A (es) Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor.
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
MXPA02010627A (es) Derivados de 2-acil-indol y su uso como farmaco antitumoral.
MXPA02011370A (es) Iminoazinas substituidas.
MXPA03012013A (es) Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor.
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
WO2002030870A3 (de) Substituierte c-cyclohexylmethylamin-derivate
YU30603A (sh) Derivati premošćenog piperazina
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.